Medegen and Bard joint packaging deal
This article was originally published in The Gray Sheet
Executive SummaryMedegen announces Aug. 18 it will include its MaxPlus Clear needleless access device in peripherally inserted central catheter (PICC) kits sold by C.R. Bard. Medegen's Maximus division says the kits will help reduce common catheter complications such as bloodstream infection and catheter occlusion. Bard Access Systems recently launched its PowerPICC SOLO device for contrast enhanced CT scans
You may also be interested in...
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.